Catalysis from A to Z

Catalysis from A to Z
Catalysis from A to Z

The updated fourth edition of this successful encyclopedia contains 40% more high-quality content from over 200 international experts in four volumes. Comprehensive, succinct, and unrivaled, it includes all the knowledge scientists need on homogeneous, heterogeneous and biochemical catalysis in easy-to-use, compact entries for some 9,000 keywords in alphabetical order.

In this way it explains briefly the important terms for every aspect of catalysis, whether biocatalysis, homogeneous catalysis, heterogeneous catalysis, or such related topics as spectroscopy or analytical methods. These also include abbreviations, brief biographic entries of important scientists who have worked in catalysis, trade names, important catalytic processes, named reactions, reactions, and other important keywords in the general field of catalysis.

Finally, the German and French translations help non-native English speakers.


Catalysis from A to Z
A Concise Encyclopedia
Boy Cornils, Wolfgang A. Herrmann, Chi-Hues Wong, Horst-Werner Zanthoff (Hrsg.)

4. Auflage März 2013
699,- Euro
Einführungspreis gültig bis 30. Juni 2013, danach

799,- Euro
2013. XXXVIII, 2438 Seiten, 4 Bände, Hardcover
1900 Abb.
ISBN 978-3-527-33307-3 - Wiley-VCH, Weinheim

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.